MENU
RSPH
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

RSPH stock forecast, quote, news & analysis

The investment seeks to track the investment results (before fees and expenses) of the S&P 500® Equal Weight Health Care Index (the "underlying index")... Show more

Category: #Health
Interact to see
Advertisement
A.I.Advisor
published price charts
RSPH
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for RSPH with price predictions
Oct 22, 2026

RSPH's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for RSPH turned positive on October 12, 2026. Looking at past instances where RSPH's MACD turned positive, the stock continued to rise in 44 of 50 cases over the following month. The odds of a continued upward trend are 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 09, 2026. You may want to consider a long position or call options on RSPH as a result. In 74 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.

Following a +0.99% 3-day Advance, the price is estimated to grow further. Considering data from situations where RSPH advanced for three days, in 252 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

The Aroon Indicator entered an Uptrend today. In 239 of 304 cases where RSPH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RSPH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.

RSPH broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Unitedhealth Group (NYSE:UNH), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Intuitive Surgical (NASDAQ:ISRG).

Industry description

The investment seeks to track the investment results (before fees and expenses) of the S&P 500® Equal Weight Health Care Index (the "underlying index"). The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index, which is composed of securities of all companies included in the S&P 500® Index that are classified as members of the health care sector, as defined according to the Global Industry Classification Standard (“GICS®”).

Market Cap

The average market capitalization across the Invesco S&P 500 Equal Weight Health Care ETF (RSPH) ETF is 113.36B. The market cap for tickers in the group ranges from 9.58B to 1.13T. LLY holds the highest valuation in this group at 1.13T. The lowest valued company is HSIC at 9.58B.

High and low price notable news

The average weekly price growth across all stocks in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH) ETF was 2%. For the same ETF, the average monthly price growth was 7%, and the average quarterly price growth was 30%. CRL experienced the highest price growth at 11%, while MRNA experienced the biggest fall at -14%.

Volume

The average weekly volume growth across all stocks in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH) ETF was -11%. For the same stocks of the ETF, the average monthly volume growth was 12% and the average quarterly volume growth was 1%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 63
P/E Growth Rating: 47
Price Growth Rating: 27
SMR Rating: 58
Profit Risk Rating: 70
Seasonality Score: 24 (-100 ... +100)
RSPH's MACD Histogram crosses above signal line